Forcyte Biotechnologies is putting the Focus On Force in disease.
As mechanical force underlies important processes in all cells, it is a key functional component driving various diseases - (asthma, hypertension, preterm labor, intestinal dysmotility, many others).
Forcyte is commercializing the (UCLA-developed) FLECS Technology Platform for high-throughput analysis of contractile cell force. We develop assays, build hardware, supply software, and perform services to functionally characterize cellular force in high-throughput, down to the single-cell level!
Our mission is to:
1) enable the budding field of "Force Biology" to automate their data collection in a standardized format to allow for direct comparison between studies, and to ultimately remove the barriers to entry for all researchers
2) provide functional high-throughput data on cellular force to support drug development in pharma, including phenotypic drug discovery, functional quantification / dose-response, toxicology, off-target effects, and general confirmation that desired contractile function is ultimately achieved
See our website for more info!
Location: United States, California, Los Angeles
Employees: 1-10
Total raised: $5.7M
Founded date: 2017
Investors 1
| Date | Name | Website |
| 19.01.2022 | Y Combinat... | ycombinato... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 02.06.2022 | - | $5.7M | - |
Mentions in press and media 2
| Date | Title | Description | Source |
| 02.06.2022 | Forcyte Biotechnologies Secures Funding; Totals $5.7M | Forcyte Biotechnologies, a Los Angeles, CA-based tech-enabled drug discovery company targeting disea... | finsmes.co... |
| 24.03.2021 | Y Combinator’s biotech startups incubate a new generation of... | Medical and biotech had a strong showing at Y Combinator’s latest demo day, with nearly a dozen comp... | techcrunch... |